Cited 53 times in
Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박준용 | - |
dc.date.accessioned | 2014-12-18T09:47:25Z | - |
dc.date.available | 2014-12-18T09:47:25Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2314-6133 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/88834 | - |
dc.description.abstract | AIM: Recently, the utility of tumor markers in the hepatocellular carcinoma (HCC) field has received a good deal of attention. Here, we review and summarize the results of studies on the roles played by the α -fetoprotein (AFP) and prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) responses in terms of the monitoring of outcomes and prediction of prognosis after various HCC treatments. METHODS: Studies lodged in PUBMED and that satisfied our inclusion criteria were reviewed. RESULTS: We reviewed 12 studies measuring both AFP and PIVKA-II responses in HCC patients treated in various ways. The results are presented by treatment modality. CONCLUSION: Measurement of AFP and PIVKA II marker levels before and after HCC treatment is clinically useful in monitoring of treatment outcomes and prognosis and in predicting recurrence and survival. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.relation.isPartOf | BIOMED RESEARCH INTERNATIONAL | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Biomarkers/blood | - |
dc.subject.MESH | Biomarkers, Tumor/blood | - |
dc.subject.MESH | Biomarkers, Tumor/genetics | - |
dc.subject.MESH | Carcinoma, Hepatocellular/blood | - |
dc.subject.MESH | Carcinoma, Hepatocellular/genetics* | - |
dc.subject.MESH | Carcinoma, Hepatocellular/pathology | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms/blood | - |
dc.subject.MESH | Liver Neoplasms/genetics* | - |
dc.subject.MESH | Liver Neoplasms/pathology | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Protein Precursors/blood | - |
dc.subject.MESH | Protein Precursors/genetics* | - |
dc.subject.MESH | Prothrombin/genetics* | - |
dc.subject.MESH | Survival Analysis | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Vitamin K/genetics | - |
dc.subject.MESH | Vitamin K/metabolism | - |
dc.subject.MESH | alpha-Fetoproteins/genetics* | - |
dc.subject.MESH | alpha-Fetoproteins/metabolism | - |
dc.title | Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Hana Park | - |
dc.contributor.googleauthor | Jun Yong Park | - |
dc.identifier.doi | 10.1155/2013/310427 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01675 | - |
dc.relation.journalcode | J00315 | - |
dc.identifier.eissn | 2314-6141 | - |
dc.identifier.pmid | 24455683 | - |
dc.subject.keyword | Biomarkers/blood | - |
dc.subject.keyword | Biomarkers, Tumor/blood | - |
dc.subject.keyword | Biomarkers, Tumor/genetics | - |
dc.subject.keyword | Carcinoma, Hepatocellular/blood | - |
dc.subject.keyword | Carcinoma, Hepatocellular/genetics* | - |
dc.subject.keyword | Carcinoma, Hepatocellular/pathology | - |
dc.subject.keyword | Humans | - |
dc.subject.keyword | Liver Neoplasms/blood | - |
dc.subject.keyword | Liver Neoplasms/genetics* | - |
dc.subject.keyword | Liver Neoplasms/pathology | - |
dc.subject.keyword | Prognosis | - |
dc.subject.keyword | Protein Precursors/blood | - |
dc.subject.keyword | Protein Precursors/genetics* | - |
dc.subject.keyword | Prothrombin/genetics* | - |
dc.subject.keyword | Survival Analysis | - |
dc.subject.keyword | Treatment Outcome | - |
dc.subject.keyword | Vitamin K/genetics | - |
dc.subject.keyword | Vitamin K/metabolism | - |
dc.subject.keyword | alpha-Fetoproteins/genetics* | - |
dc.subject.keyword | alpha-Fetoproteins/metabolism | - |
dc.contributor.alternativeName | Park, Jun Yong | - |
dc.contributor.affiliatedAuthor | Park, Jun Yong | - |
dc.rights.accessRights | free | - |
dc.citation.volume | 2013 | - |
dc.citation.startPage | 310427 | - |
dc.identifier.bibliographicCitation | BIOMED RESEARCH INTERNATIONAL, Vol.2013 : 310427, 2013 | - |
dc.identifier.rimsid | 33651 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.